Skip to main content
🎂 — | ♂/♀ M/F | ⚖️ — kg | 📏 — cm | BMI — | 👟 —
⚡ 88%
🩺 Allergies And Immunity

ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯁꯔꯨ ꯇꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ ꯀꯌꯥ ꯂꯩꯕ꯭ꯔꯥ? ꯃꯁꯤ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ. (ꯀ꯭ꯔꯣꯅꯤꯛ ꯔꯤꯀꯣꯔꯗ ꯃꯜꯇꯤꯐꯣꯀꯦꯜ ꯑꯣꯁ꯭ꯇꯤꯑꯣꯃꯥꯏꯂꯥꯏꯇꯤꯁ)

MBBS
Medically Reviewed by MBBS ✓ Medically Reviewed
📅 Updated: Jul 15, 2026 • ⏱ 7 min read • ꯑꯦꯗꯤꯇꯣꯔꯤꯌꯜ ꯄꯣꯂꯤꯁꯤ꯫
ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯁꯔꯨ ꯇꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ ꯀꯌꯥ ꯂꯩꯕ꯭ꯔꯥ? ꯃꯁꯤ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ. (ꯀ꯭ꯔꯣꯅꯤꯛ ꯔꯤꯀꯣꯔꯗ ꯃꯜꯇꯤꯐꯣꯀꯦꯜ ꯑꯣꯁ꯭ꯇꯤꯑꯣꯃꯥꯏꯂꯥꯏꯇꯤꯁ)
Table of Contents ▾

ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯑꯌꯥꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯃꯈꯣꯌꯒꯤ ꯈꯣꯡ, ꯃꯈꯨꯠ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯏ ꯍꯥꯌꯅꯥ ꯋꯥꯀꯠꯄꯥ ꯌꯥꯕ꯭ꯔꯥ? ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯑꯩꯈꯣꯌꯅꯥ ꯈꯜꯂꯤ ꯃꯗꯨꯗꯤ ꯃꯁꯤ ꯂꯥꯟꯊꯦꯡꯅꯕꯗꯥ ꯅꯠꯠꯔꯒꯥ "ꯑꯋꯥꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯒꯤ" ꯏꯆꯝ ꯆꯝꯕꯥ ꯀꯦꯁ ꯑꯃꯈꯛꯇꯅꯤ꯫ ꯑꯗꯨꯕꯨ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯋꯥꯕꯥ ꯑꯁꯤ ꯅꯨꯃꯤꯠ ꯀꯌꯥꯅꯤ ꯅꯠꯠꯔꯒꯥ ꯅꯨꯃꯤꯠ ꯀꯌꯥꯅꯤ ꯂꯩꯔꯒꯥ ꯅꯨꯃꯤꯠ ꯈꯔꯅꯤꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯍꯟꯊꯔꯛꯂꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯂꯥꯀꯄꯥ ꯇꯥꯔꯕꯗꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯈꯔꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯊꯦꯡꯅꯒꯗꯕꯅꯤ꯫ ꯉꯁꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯁꯔꯨꯒꯤ ꯑꯅꯥꯕꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯕꯥ ꯌꯥꯝꯅꯥ ꯊꯨꯅꯥ ꯊꯣꯀꯄꯥ ꯑꯗꯨꯕꯨ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯔꯤ꯫

⚡ Interactive Clinical Tool
⚖️

BMI Calculator

Know your body mass index (BMI) and weight classification

Open Interactive Calculator →

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ. ꯍꯥꯌꯅꯥ ꯈꯉꯅꯕꯥ ꯀ꯭ꯔꯣꯅꯤꯛ ꯔꯤꯀꯣꯔꯗ ꯃꯜꯇꯤꯐꯣꯀꯦꯜ ꯑꯣꯁ꯭ꯇꯤꯑꯣꯃꯥꯏꯂꯥꯏꯇꯤꯁ ꯑꯁꯤ ꯑꯣꯇꯣꯏꯝꯌꯨꯟ ꯂꯥꯌꯅꯥ ꯑꯃꯅꯤ . ꯍꯧꯖꯤꯛꯇꯤ ꯃꯁꯤ ꯀꯔꯤꯅꯣ ꯍꯥꯌꯅꯥ ꯑꯗꯣꯝꯅꯥ ꯈꯅꯕꯤꯔꯃꯒꯅꯤ꯫ ꯑꯩꯈꯣꯌꯒꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯑꯁꯤ ꯂꯩꯕꯥꯛ ꯑꯃꯥ ꯉꯥꯀꯊꯣꯀꯄꯥ ꯉꯝꯕꯥ ꯂꯥꯟꯃꯤ ꯑꯃꯥ ꯑꯣꯏꯅꯥ ꯈꯅꯕꯤꯌꯨ꯫ ꯂꯥꯟꯃꯤ ꯑꯁꯤꯒꯤ ꯊꯕꯛ ꯑꯁꯤ ꯃꯄꯥꯟ ꯂꯩꯕꯥꯛꯀꯤ ꯌꯦꯛꯅꯕꯥ, ꯍꯥꯌꯕꯗꯤ ꯚꯥꯏꯔꯁ ꯑꯃꯁꯨꯡ ꯕꯦꯛꯇꯦꯔꯤꯌꯥꯒꯥ ꯂꯥꯟꯊꯦꯡꯅꯗꯨꯅꯥ ꯑꯩꯈꯣꯌꯕꯨ ꯂꯥꯌꯅꯥꯁꯤꯡꯗꯒꯤ ꯉꯥꯀꯊꯣꯀꯄꯅꯤ꯫

ꯑꯗꯨꯕꯨ ꯑꯣꯇꯣꯏꯝꯌꯨꯟ ꯂꯥꯌꯅꯥ ꯑꯃꯗꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯏꯁꯥꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯑꯁꯣꯏꯕꯥ ꯑꯃꯥ ꯊꯣꯀꯏ ꯑꯃꯁꯨꯡ ꯃꯄꯥꯟ ꯂꯩꯕꯥꯛꯀꯤ ꯂꯥꯟꯃꯤꯁꯤꯡꯒꯤ ꯃꯍꯨꯠꯇꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯏꯁꯥꯒꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯍꯀꯆꯥꯡ ꯐꯕꯥ ꯁꯔꯨꯀꯁꯤꯡꯗꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯏ꯫ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯗꯥ, ꯃꯁꯤꯒꯤ "ꯑꯔꯥꯅꯕꯥ ꯑꯦꯇꯦꯛ" ꯑꯁꯤ ꯑꯩꯈꯣꯌꯒꯤ ꯏꯁꯥꯒꯤ ꯁꯔꯨꯗꯥ ꯂꯃꯖꯤꯡꯏ . ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯑꯁꯤꯅꯥ ꯃꯔꯝ ꯑꯃꯠꯇꯥ ꯂꯩꯇꯅꯥ ꯍꯀꯆꯥꯡꯗꯥ ꯁꯔꯨ ꯇꯥꯡ ꯑꯃꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯃꯗꯒꯤ ꯍꯦꯅꯕꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯗꯨꯅꯥ ꯏꯅꯐ꯭ꯂꯦꯃꯦꯁꯟ (inflammation) ꯊꯣꯀꯍꯜꯂꯤ, ꯃꯁꯤꯅꯥ ꯁꯣꯛ-ꯄꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯍꯜꯂꯤ꯫

ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯗꯤ ꯀꯟꯗꯤꯁꯟ ꯑꯁꯤ ꯕꯦꯛꯇꯦꯔꯤꯌꯥꯒꯤ ꯏꯅꯐꯦꯛꯁꯟ ꯑꯃꯠꯇꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯅꯠꯇꯦ꯫ ꯃꯔꯝ ꯑꯁꯤꯅꯥ ꯃꯁꯤꯕꯨ ꯀ꯭ꯔꯣꯅꯤꯛ ꯅꯟ-ꯕꯦꯛꯇꯦꯔꯤꯑꯦꯜ ꯑꯣꯁ꯭ꯇꯤꯑꯣꯃꯥꯏꯂꯥꯏꯇꯤꯁ (CNO) ꯍꯥꯌꯅꯥꯁꯨ ꯀꯧꯏ꯫ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯁꯤ.ꯑꯦꯟ.ꯑꯣ.ꯒꯤ ꯈꯔꯥ ꯍꯦꯟꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯃꯑꯣꯡ ꯑꯃꯅꯤ꯫

ꯁꯤ ꯑꯥꯔ ꯑꯦꯝ ꯑꯣ ꯁꯦꯝꯕꯒꯤ ꯑꯀꯛꯅꯕꯥ ꯃꯔꯝ ꯑꯃꯥ ꯂꯩꯕꯔꯥ?

ꯇꯁꯦꯡꯕꯗꯤ ꯗꯣꯛꯇꯔꯁꯤꯡꯅꯥ ꯍꯧꯖꯤꯛ ꯐꯥꯑꯣꯕꯥ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ . ꯃꯁꯤ ꯕꯦꯛꯇꯦꯔꯤꯌꯥ ꯅꯠꯠꯔꯒꯥ ꯚꯥꯏꯔꯁ ꯏꯅꯐꯦꯛꯁꯟ ꯑꯃꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯅꯠꯇꯦ꯫ ꯃꯁꯤ ꯃꯔꯝ ꯑꯃꯠꯇꯥ ꯂꯩꯇꯅꯥ ꯑꯦꯛꯇꯤꯕ ꯑꯣꯏꯕꯥ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯈꯛꯇꯅꯤ꯫

ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯃꯁꯤꯒꯥ ꯖꯦꯅꯦꯇꯤꯛ ꯂꯤꯉ꯭ꯛ ꯑꯃꯥ ꯂꯩꯕꯥ ꯌꯥꯏ ꯍꯥꯌꯕꯒꯤ ꯑꯀꯤꯕꯥ ꯈꯔꯥ ꯂꯩ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ, ꯏꯃꯨꯡ ꯑꯃꯒꯤ ꯃꯤꯑꯣꯏ ꯀꯌꯥꯗꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯁꯤ ꯂꯩꯔꯦ ꯍꯥꯌꯅꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯔꯀꯏ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯃꯈꯥ ꯇꯥꯅꯥ ꯊꯤꯖꯤꯅꯕꯥ ꯃꯊꯧ ꯇꯥꯏ꯫

ꯃꯃꯥ-ꯃꯄꯥ ꯑꯣꯏꯕꯁꯤꯡ ꯑꯣꯏꯅꯥ, ꯅꯍꯥꯛꯅꯥ ꯊꯦꯡꯅꯔꯀꯄꯥ ꯌꯥꯕꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯆꯥꯎꯕꯥ ꯑꯀꯤꯕꯥ ꯑꯃꯗꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯁꯤ ꯀꯦꯟꯁꯔꯒꯥ ꯃꯔꯤ ꯂꯩꯅꯕꯔꯥ ꯍꯥꯌꯕꯁꯤꯅꯤ꯫ ꯁꯤ ꯑꯥꯔ ꯑꯦꯝ ꯑꯣ ꯑꯁꯤ ꯀꯦꯟꯁꯔ ꯅꯠꯇꯦ . ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯃꯁꯤꯅꯥ ꯕꯣꯟ ꯀꯦꯟꯁꯔ ꯈꯔꯒꯥ ꯃꯥꯟꯅꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯂꯩꯕꯥ ꯌꯥꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯑꯆꯨꯝꯕꯥ ꯂꯥꯏꯑꯣꯡ ꯈꯪꯗꯣꯛꯅꯕꯒꯤꯗꯃꯛ ꯗꯣꯛꯇꯔ ꯑꯃꯒꯥ ꯇꯥꯟꯅꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯀꯅꯥꯅꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯅꯥꯕꯥ ꯌꯥꯕꯒꯦ?

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯑꯉꯥꯡꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯅꯍꯥ ꯑꯣꯏꯔꯤꯕꯥ ꯑꯍꯂꯁꯤꯡꯗꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯀꯃꯟ ꯑꯣꯏꯅꯥ ꯎꯕꯥ ꯐꯪꯏ꯫ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯆꯍꯤ 9-10ꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯈꯪꯗꯣꯀꯏ꯫ ꯀꯟꯗꯤꯁꯟ ꯑꯁꯤ ꯅꯨꯄꯥꯃꯆꯥꯁꯤꯡꯗꯒꯤ ꯅꯨꯄꯤꯃꯆꯥꯁꯤꯡꯗꯥ ꯈꯔꯥ ꯍꯦꯟꯅꯥ ꯀꯃꯟ ꯑꯣꯏ꯫

ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯀꯃꯟ ꯑꯣꯏꯕꯥ ꯂꯥꯌꯅꯥ ꯑꯃꯅꯤ, ꯑꯗꯨꯕꯨ ꯗꯣꯛꯇꯔꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯃꯤꯌꯥꯝ ꯄꯨꯝꯕꯅꯥ ꯂꯥꯌꯅꯥ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯍꯦꯟꯅꯥ ꯈꯉꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯂꯥꯌꯅꯥ ꯑꯁꯤꯅꯥ ꯅꯥꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯒꯤ ꯃꯁꯤꯡ ꯑꯁꯤ ꯈꯔꯥ ꯍꯦꯅꯒꯠꯂꯛꯂꯤ꯫

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯍꯀꯆꯥꯡꯒꯤ ꯁꯔꯨ ꯑꯃꯍꯦꯛꯇꯗꯥ ꯁꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯕꯨ ꯃꯁꯤꯅꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯀꯃꯟ ꯑꯣꯏꯅꯥ ꯑꯉꯥꯡꯁꯤꯡꯒꯤ ꯈꯣꯡ, ꯈꯣꯡꯎꯞ ꯑꯃꯁꯨꯡ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡꯗꯥ ꯁꯣꯀꯍꯜꯂꯤ . ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯁꯤ ꯈꯪꯍꯧꯗꯅꯥ ꯂꯥꯀꯄꯥ ꯌꯥꯏ, ꯅꯨꯃꯤꯠ ꯈꯔꯅꯤꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯍꯟꯊꯔꯀꯄꯥ ꯌꯥꯏ, ꯑꯃꯁꯨꯡ ꯃꯗꯨꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯂꯥꯀꯄꯥ ꯌꯥꯏ꯫ ꯃꯁꯤꯕꯨ ꯐ꯭ꯂꯦꯌꯔ-ꯑꯞ ꯑꯃꯁꯨꯡ ꯔꯤꯃꯤꯁꯟ ꯍꯥꯌꯅꯥ ꯀꯧꯏ꯫

ꯑꯁꯤꯒꯨꯝꯕꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯁꯤ ꯌꯦꯡꯁꯤ꯫

ꯂꯥꯏꯑꯣꯡ꯫ ꯏꯆꯝ ꯆꯝꯕꯥ ꯄꯥꯎꯈꯨꯝ ꯑꯃꯥ꯫
ꯑꯅꯥꯕ ꯃꯁꯤ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯀꯃꯟ ꯑꯣꯏꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯂꯥꯏꯑꯣꯡꯅꯤ꯫ ꯑꯁꯣꯀꯄꯥ ꯁꯔꯨ ꯇꯥꯡ ꯅꯠꯠꯔꯒꯥ ꯃꯅꯥꯛ ꯅꯀꯄꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯑꯅꯥꯕꯥ ꯊꯣꯀꯏ꯫
ꯖꯣꯏꯟꯇ ꯏꯅꯐ꯭ꯂꯦꯃꯦꯁꯟ ꯂꯩꯕꯥ꯫ ꯑꯁꯣꯀꯄꯥ ꯁꯔꯨ ꯇꯥꯡꯒꯤ ꯃꯅꯥꯛꯇꯥ ꯂꯩꯕꯥ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡ ꯑꯁꯤ ꯑꯔꯊ꯭ꯔꯥꯏꯇꯤꯁꯀꯥ ꯃꯥꯟꯅꯅꯥ ꯁꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯁꯣꯀꯄꯥ ꯌꯥꯏ꯫
ꯕꯣꯟ ꯗꯤꯐꯣꯔꯃꯤꯇꯤꯁꯤꯡ ꯂꯩꯕꯥ꯫ ꯂꯥꯌꯅꯥ ꯑꯁꯤꯅꯥ ꯑꯉꯥꯡ ꯑꯃꯒꯤ ꯒ꯭ꯔꯣꯊ ꯄ꯭ꯂꯦꯇꯁꯤꯡꯗꯥ ꯁꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯒ꯭ꯔꯣꯊ ꯄ꯭ꯂꯦꯇꯁꯤꯡ ꯍꯥꯌꯕꯁꯤ ꯑꯉꯥꯡ ꯑꯃꯅꯥ ꯆꯥꯎꯈꯠꯂꯀꯄꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ ꯃꯐꯃꯁꯤꯡꯅꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯍꯥꯌꯔꯤꯕꯁꯤꯡ ꯑꯁꯤ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯛꯂꯕꯗꯤ, ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡ ꯑꯁꯤ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ (ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ, ꯈꯣꯡ ꯑꯃꯅꯥ ꯑꯇꯣꯞꯄꯥ ꯑꯃꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯀꯨꯄꯁꯤꯅꯕꯥ ꯌꯥꯏ)꯫
ꯒ꯭ꯔꯣꯊ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯂꯩꯇꯕꯁꯨ, ꯑꯉꯥꯡ ꯑꯗꯨꯒꯤ ꯒ꯭ꯔꯣꯊ ꯑꯁꯤ ꯊꯥꯖꯕꯒꯨꯝꯅꯥ ꯌꯥꯡꯅꯥ ꯆꯥꯎꯈꯠꯄꯥ ꯉꯃꯗꯕꯥ ꯌꯥꯏ꯫
ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ꯫ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯁꯤ ꯍꯦꯟꯅꯥ ꯁꯣꯀꯆꯤꯜꯂꯀꯄꯒꯤ ꯃꯇꯃꯁꯤꯡꯗꯥ, ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯂꯦꯞꯇꯅꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ ꯑꯃꯁꯨꯡ ꯂꯦꯡ-ꯑꯣꯠꯄꯥ ꯐꯥꯎꯕꯥ ꯌꯥꯏ꯫
ꯐ꯭ꯔꯦꯀꯆꯔꯒꯤ ꯔꯤꯁ꯭ꯛ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ꯫ ꯏꯅꯐ꯭ꯂꯦꯃꯦꯁꯅꯅꯥ ꯁꯣꯀꯍꯜꯂꯕꯥ ꯁꯔꯨꯁꯤꯡ ꯑꯁꯤ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯁ꯭ꯄꯥꯏꯅꯦꯜ ꯀꯣꯔꯗꯇꯥ ꯁꯣꯀꯍꯜꯂꯕꯗꯤ, ꯑꯄꯤꯀꯄꯥ ꯇ꯭ꯔꯥꯎꯃꯥ ꯑꯃꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯍꯦꯟꯅꯥ ꯁꯣꯀꯆꯤꯜꯂꯀꯄꯥ ꯌꯥꯏ꯫

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯒꯤ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯃꯇꯧ ꯀꯔꯝꯅꯥ ꯑꯆꯨꯝꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯈꯉꯗꯣꯀꯄꯥ ꯌꯥꯕꯒꯦ?

ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯇꯣꯏꯅꯥ ꯊꯣꯀꯄꯥ ꯂꯥꯌꯅꯥ ꯑꯃꯅꯤ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯁꯤ ꯈꯪꯗꯣꯀꯄꯥ ꯍꯥꯌꯕꯁꯤ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯁꯤꯡꯅꯕꯥ ꯑꯃꯥ ꯑꯣꯏꯕꯥ ꯌꯥꯏ꯫ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯌꯦꯡꯁꯤꯅꯒꯅꯤ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡꯒꯤ ꯃꯔꯃꯗꯥ ꯍꯪꯒꯅꯤ꯫ ꯃꯍꯧꯁꯥꯅꯥ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯈꯪꯗꯣꯀꯄꯗꯥ ꯊꯥ ꯀꯌꯥ ꯅꯠꯠꯔꯒꯥ ꯆꯍꯤ ꯑꯃꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯆꯪꯕꯥ ꯌꯥꯏ꯫

ꯗꯥꯏꯑꯦꯒ꯭ꯅꯣꯁꯤꯁ ꯀꯅꯐꯥꯔꯝ ꯇꯧꯅꯕꯥ ꯇꯦꯁ꯭ꯠ ꯀꯌꯥ ꯑꯃꯥ ꯄꯥꯡꯊꯣꯀꯏ꯫

  • ꯏꯃꯦꯖꯤꯡ ꯇꯦꯁ꯭ꯇꯁꯤꯡ: ꯑꯦꯛꯁ-ꯔꯦ ꯑꯃꯁꯨꯡ ꯑꯦꯝ.ꯑꯥꯔ.ꯑꯥꯏ.
  • ꯕ꯭ꯂꯗ ꯇꯦꯁ꯭ꯠ: ꯃꯁꯤꯅꯥ ꯍꯀꯆꯥꯡꯗꯥ ꯏꯅꯐ꯭ꯂꯦꯃꯦꯁꯅꯒꯤ ꯆꯥꯡ (ESR, CRP) ꯌꯦꯡꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ ꯑꯃꯁꯨꯡ ꯑꯇꯩ ꯏꯅꯐꯦꯛꯁꯟ ꯅꯠꯠꯔꯒꯥ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯊꯤꯡꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫
  • ꯖꯦꯅꯦꯇꯤꯛ ꯇꯦꯁ꯭ꯇꯁꯤꯡ: ꯀꯦꯁ ꯈꯔꯗꯗꯤ, ꯑꯇꯣꯞꯄꯥ ꯖꯦꯅꯦꯇꯤꯛ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯂꯥꯀꯁꯤꯟꯅꯕꯥ ꯇꯦꯁ꯭ꯇꯁꯤꯡ ꯑꯁꯤꯁꯨ ꯃꯊꯧ ꯇꯥꯕꯥ ꯌꯥꯏ꯫

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯒꯤ ꯂꯥꯌꯦꯡꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?

ꯃꯇꯝ ꯑꯁꯤꯗꯥ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯒꯤ ꯂꯥꯌꯦꯡ ꯑꯃꯠꯇꯥ ꯂꯩꯇꯦ꯫ ꯑꯗꯨꯕꯨ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯂꯩꯔꯣꯏꯗꯕꯅꯤ꯫ ꯐꯪꯂꯤꯕꯥ ꯂꯥꯏꯌꯦꯡꯁꯤꯡꯅꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯥ ꯉꯝꯃꯤ, ꯏꯅꯐ꯭ꯂꯦꯃꯦꯁꯟ ꯍꯟꯊꯍꯅꯕꯥ ꯉꯝꯃꯤ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯕꯨ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯅꯣꯔꯃꯦꯜ ꯑꯣꯏꯕꯥ ꯄꯨꯟꯁꯤ ꯑꯃꯥ ꯍꯤꯡꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ .

ꯗꯣꯛꯇꯔꯅꯥ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯂꯥꯏꯌꯦꯡꯁꯤꯡ ꯑꯁꯤ ꯔꯤꯀꯃꯦꯟꯗ ꯇꯧꯕꯥ ꯌꯥꯏ:

  • ꯅꯟ-ꯁ꯭ꯇꯦꯔꯣꯏꯗ ꯑꯦꯟꯇꯤ-ꯏꯅꯐ꯭ꯂꯦꯃꯦꯇꯔꯤ ꯗ꯭ꯔꯒꯁꯤꯡ (NSAIDs): ꯃꯁꯤ ꯏꯕꯨꯞꯔꯣꯐꯦꯅꯒꯨꯝꯕꯥ ꯑꯩꯈꯣꯌ ꯄꯨꯝꯅꯃꯛꯅꯥ ꯈꯪꯂꯤꯕꯥ ꯄꯦꯏꯅꯀꯤꯂꯔꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯑꯦꯟꯇꯤ-ꯏꯅꯐ꯭ꯂꯦꯃꯦꯇꯔꯤ ꯗ꯭ꯔꯒꯁꯤꯡꯅꯤ꯫ ꯃꯁꯤ ꯍꯣꯠꯅꯔꯤꯕꯥ ꯑꯍꯥꯅꯕꯥ ꯂꯥꯏꯌꯦꯡꯅꯤ꯫ ꯆꯥꯎꯔꯥꯛꯅꯥ ꯑꯉꯥꯡꯁꯤꯡꯒꯤ 50%ꯗꯤ ꯃꯈꯣꯌꯗꯥ ꯐꯖꯅꯥ ꯔꯦꯁꯄꯣꯟꯁ ꯇꯧꯏ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯑꯁꯤ ꯃꯇꯝ ꯁꯥꯡꯅꯥ ꯂꯧꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯀꯤꯗꯅꯤ ꯑꯃꯁꯨꯡ ꯂꯤꯚꯔꯒꯤ ꯐꯉ꯭ꯀꯁꯟ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯌꯦꯡꯁꯤꯅꯒꯅꯤ꯫
  • ꯗꯤꯖꯤꯖ-ꯃꯣꯗꯤꯐꯥꯏꯌꯤꯡ ꯑꯦꯟꯇꯤꯔꯤꯎꯃꯦꯇꯤꯛ ꯗ꯭ꯔꯒꯁꯤꯡ (DMARDs): ꯀꯔꯤꯒꯨꯝꯕꯥ NSAIDꯁꯤꯡ ꯈꯛꯇꯅꯥ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯗ꯭ꯔꯕꯗꯤ, ꯗ꯭ꯔꯒꯁꯤꯡꯒꯤ ꯀ꯭ꯂꯥꯁ ꯑꯁꯤꯅꯥ ꯁꯤꯖꯤꯟꯅꯔꯤꯕꯥ ꯗ꯭ꯔꯒꯁꯤꯡꯒꯤ ꯃꯊꯪꯒꯤ ꯀꯥꯡꯂꯨꯞ ꯑꯁꯤꯅꯤ꯫ ꯗ꯭ꯔꯒꯁꯤꯡ ꯑꯁꯤꯅꯥ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯑꯁꯤ ꯆꯥꯡ ꯈꯔꯗꯥ ꯁꯣꯀꯍꯟꯗꯨꯅꯥ ꯊꯕꯛ ꯇꯧꯏ, ꯃꯁꯤꯅꯥ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯊꯣꯀꯍꯜꯂꯤꯕꯥ ꯑꯔꯥꯅꯕꯥ ꯑꯦꯇꯦꯀꯁꯤꯡ ꯊꯤꯡꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫ ꯗ꯭ꯔꯒꯁꯤꯡ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯀꯥꯟꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯑꯋꯥꯕꯥ ꯄꯨꯝꯅꯃꯛ ꯈꯪꯍꯜꯂꯛꯀꯅꯤ꯫
  • ꯄꯨꯟꯁꯤ ꯃꯍꯤꯡꯗꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯥ: ꯱.ꯑꯅꯥꯕꯥ ꯃꯇꯃꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯃꯈꯣꯌꯒꯤ ꯂꯝꯕꯤ-ꯊꯣꯡ ꯑꯃꯁꯨꯡ ꯂꯥꯞꯅꯥ ꯆꯠꯄꯒꯤ ꯊꯕꯛ-ꯊꯧꯔꯃꯁꯤꯡ ꯑꯗꯨ ꯂꯤꯃꯤꯠ ꯇꯧꯕꯥ ꯃꯊꯧ ꯇꯥꯕꯥ ꯌꯥꯏ꯫ ꯐꯤꯖꯤꯀꯦꯜ ꯊꯦꯔꯥꯄꯤꯁ꯭ꯠ ꯅꯠꯠꯔꯒꯥ ꯑꯣꯛꯌꯨꯄꯦꯁꯅꯦꯜ ꯊꯦꯔꯥꯄꯤꯁ꯭ꯠ ꯑꯃꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯑꯦꯛꯁꯔꯁꯥꯏꯖ ꯌꯥꯎꯅꯥ ꯅꯨꯃꯤꯠ ꯈꯨꯗꯤꯡꯒꯤ ꯑꯣꯏꯕꯥ ꯊꯕꯛ-ꯊꯧꯔꯃꯁꯤꯡ ꯀꯔꯝꯅꯥ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯇꯝꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫

ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯑꯇꯣꯞꯄꯥ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯂꯩꯕ꯭ꯔꯥ?

ꯍꯣꯌ, ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯅꯥꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯑꯇꯣꯞꯄꯥ ꯑꯣꯇꯣꯏꯝꯌꯨꯟ ꯂꯥꯌꯅꯥ ꯀꯌꯥ ꯂꯥꯀꯄꯒꯤ ꯔꯤꯁ꯭ꯛ ꯈꯔꯥ ꯂꯩ꯫

  • ꯏꯅꯐ꯭ꯂꯦꯃꯦꯇꯔꯤ ꯕꯣꯋꯦꯜ ꯗꯤꯖꯤꯖ (IBD): ꯃꯁꯤꯁꯨ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯗꯥꯏꯖꯦꯁ꯭ꯇꯤꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯗꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯕꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯅꯤ꯫
  • ꯁꯣꯔꯤꯌꯥꯁꯤꯁ: ꯃꯁꯤ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯍꯜꯂꯤꯕꯥ ꯑꯣꯇꯣꯏꯝꯌꯨꯟ ꯂꯥꯌꯅꯥ ꯑꯃꯅꯤ꯫
  • ꯑꯦꯝꯞꯂꯤꯐꯥꯏꯗ ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ: ꯃꯁꯤ ꯈꯔꯥ ꯍꯦꯟꯅꯥ ꯀꯝꯄꯤꯇꯤꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯅꯤ꯫ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯔꯤꯃꯤꯁꯅꯗꯥ ꯂꯩꯕꯥ ꯃꯇꯃꯗꯁꯨ, ꯃꯔꯝ ꯑꯃꯠꯇꯗꯥ ꯃꯈꯥ ꯇꯥꯅꯥ ꯃꯁꯜ ꯁꯣꯀꯄꯥ ꯌꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯑꯅꯥꯕꯥ ꯑꯁꯤ ꯑꯆꯝꯕꯥ ꯄꯦꯟ ꯀꯤꯂꯔꯁꯤꯡꯅꯥ ꯀꯣꯀꯍꯅꯕꯥ ꯉꯃꯗꯦ꯫

ꯂꯥꯌꯅꯥ ꯑꯁꯤꯒꯤ ꯄ꯭ꯔꯣꯒ꯭ꯅꯣꯁꯤꯁ ꯑꯁꯤ ꯀꯔꯤꯅꯣ?

ꯅꯨꯡꯉꯥꯏꯕꯥ ꯄꯥꯎ ꯑꯃꯗꯤ ꯄꯦꯁꯦꯟꯇꯁꯤꯡꯒꯤ ꯆꯥꯎꯔꯥꯛꯅꯥ 40%ꯗꯤ ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯑꯍꯥꯅꯕꯥ ꯆꯍꯤ 1-5ꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯔꯤꯃꯤꯁꯟ ꯐꯪꯏ꯫ ꯃꯁꯤꯅꯥ ꯇꯥꯀꯄꯗꯤ ꯑꯅꯥꯕꯥ ꯑꯃꯁꯨꯡ ꯑꯇꯩ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯗꯨ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯂꯩꯔꯦ, ꯏꯅꯐ꯭ꯂꯦꯃꯦꯁꯟ ꯅꯠꯠꯔꯒꯥ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯗꯤꯁꯐꯉ꯭ꯀꯁꯟ ꯑꯃꯠꯇꯥ ꯂꯩꯇꯦ꯫ ꯃꯗꯨꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯅꯣꯔꯃꯦꯜ, ꯑꯦꯛꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯄꯨꯟꯁꯤ ꯑꯃꯥ ꯍꯤꯡꯕꯥ ꯌꯥꯏ꯫

ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯐꯒꯠꯂꯕꯁꯨ, ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯃꯣꯅꯤꯇꯔ ꯇꯧꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯅꯍꯥꯛꯅꯥ ꯔꯤꯌꯨꯃꯦꯇꯣꯂꯣꯖꯤꯁ꯭ꯠ ꯑꯃꯒꯤ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯈꯥꯗꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯗꯨꯗꯥ ꯃꯈꯥ ꯇꯥꯅꯥ ꯆꯠꯀꯗꯕꯅꯤ꯫ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯂꯥꯛꯂꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯌꯦꯡꯅꯕꯒꯤꯗꯃꯛ ꯅꯍꯥꯛꯅꯥ ꯑꯦꯝ.ꯑꯥꯔ.ꯑꯥꯏ. ꯃꯁꯤꯒꯤ ꯃꯔꯃꯗꯤ ꯆꯥꯎꯔꯥꯛꯅꯥ ꯃꯤꯑꯣꯏ 50%ꯗꯤ ꯂꯥꯏꯌꯦꯡ ꯂꯦꯄꯈ꯭ꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯑꯍꯥꯅꯕꯥ ꯆꯍꯤ ꯑꯅꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯔꯤꯂꯦꯄꯁꯟ ꯂꯩ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯗꯨ ꯑꯣꯏꯔꯕꯗꯤ, ꯅꯍꯥꯛꯅꯥ ꯂꯥꯏꯌꯦꯡ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯍꯧꯒꯗꯕꯅꯤ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯑꯁꯣꯌꯕꯥ ꯂꯩꯇꯅꯥ ꯍꯀꯆꯥꯡꯒꯤ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡꯗꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯕꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯕꯦꯛꯇꯦꯔꯤꯌꯥ ꯏꯅꯐꯦꯛꯁꯟ ꯅꯠꯠꯔꯒꯥ ꯀꯦꯟꯁꯔ ꯑꯃꯅꯤ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯉꯥꯡ ꯑꯃꯅꯥ ꯃꯈꯣꯌꯒꯤ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡꯗꯥ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯈꯣꯡ, ꯈꯣꯡꯄꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯍꯟꯖꯤꯟ ꯍꯟꯖꯤꯟ ꯑꯅꯥꯕꯥ ꯂꯩꯔꯕꯗꯤ, ꯃꯗꯨ "ꯅꯣꯔꯃꯦꯜ" ꯍꯥꯌꯅꯥ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫
  • ꯂꯥꯌꯅꯥ ꯑꯁꯤꯒꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯂꯥꯏꯌꯦꯡ ꯂꯩꯇꯕꯁꯨ, ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯁꯤ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯥ ꯉꯝꯕꯥ ꯑꯃꯁꯨꯡ ꯑꯉꯥꯡ ꯑꯗꯨꯕꯨ ꯅꯣꯔꯃꯦꯜ ꯑꯣꯏꯕꯥ, ꯑꯦꯛꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯄꯨꯟꯁꯤ ꯑꯃꯥ ꯍꯤꯡꯍꯅꯕꯥ ꯉꯝꯕꯥ ꯌꯥꯝꯅꯥ ꯏꯐꯦꯛꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯂꯥꯏꯌꯦꯡꯁꯤꯡ ꯂꯩ꯫
  • ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ.ꯅꯥ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯃꯇꯝ ꯆꯪꯕꯥ ꯌꯥꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯑꯁꯥꯑꯣꯕꯥ ꯄꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯌꯥꯝꯅꯥ ꯅꯛꯅꯥ ꯊꯕꯛ ꯇꯧꯃꯤꯟꯅꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ .
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯒꯤ ꯑꯅꯥꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯇꯩ ꯂꯥꯏꯑꯣꯡꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯆꯤꯡꯅꯕꯥ ꯂꯩꯔꯕꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯒꯗꯕꯅꯤ꯫
🔍 Search Keywords: what is chronic recurrent multifocal osteomyelitis • what is chronic recurrent multifocal osteomyelitis symptoms • what is chronic recurrent multifocal osteomyelitis causes and treatment • what is chronic recurrent multifocal osteomyelitis sri lanka • ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯁꯔꯨ ꯇꯥꯡꯒꯤ ꯑꯅꯥꯕꯥ ꯀꯌꯥ ꯂꯩꯕ꯭ꯔꯥ? ꯃꯁꯤ ꯁꯤ.ꯑꯥꯔ.ꯑꯦꯝ.ꯑꯣ. (ꯀ꯭ꯔꯣꯅꯤꯛ ꯔꯤꯀꯣꯔꯗ ꯃꯜꯇꯤꯐꯣꯀꯦꯜ ꯑꯣꯁ꯭ꯇꯤꯑꯣꯃꯥꯏꯂꯥꯏꯇꯤꯁ)

🩺 Articles For You

ꯅꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨꯅꯥ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡꯗꯥ ꯑꯅꯥꯕꯥ ꯂꯩꯕ꯭ꯔꯥ? ꯖꯨꯚꯦꯅꯥꯏꯜ ꯏꯗꯤꯑꯣꯄꯦꯊꯤꯛ ꯑꯥꯔꯊ꯭ꯔꯥꯏꯇꯤꯁ (JIA)ꯒꯤ ꯃꯔꯃꯗꯥ ꯄꯨꯝꯅꯃꯛ ꯈꯪꯖꯤꯅꯁꯤ!

ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯌꯥꯎꯗꯅꯥ ꯀꯣꯛ ꯆꯤꯀꯄꯒꯤ ꯔꯤꯂꯤꯐ! ꯂꯣ ꯕꯦꯛ ꯄꯦꯅꯒꯤ ꯑꯂꯇꯔꯅꯦꯇꯤꯚ ꯊꯦꯔꯥꯄꯤꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ꯫

ꯑꯥꯟꯗ꯭ꯔꯦ ꯑꯒꯥꯁꯤꯒꯤ ꯁꯥꯟꯅꯕꯒꯤ ꯀꯦꯔꯤꯌꯔ ꯂꯣꯏꯁꯤꯅꯈꯤꯕꯥ ꯕꯦꯛ ꯄꯦꯟ (ꯁ꯭ꯄꯣꯟꯗꯤꯂꯣꯂꯤꯁ꯭ꯇꯦꯁꯤꯁ)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯉꯁꯤ꯫

ꯑꯦꯟꯀꯤꯂꯣꯁꯤꯡ ꯁ꯭ꯄꯣꯟꯗꯤꯂꯥꯏꯇꯤꯁꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯈꯣꯡꯒꯤ ꯑꯅꯥꯕꯥ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯃꯦꯅꯦꯖ ꯇꯧꯒꯗꯒꯦ?

ꯅꯍꯥꯛꯀꯤ ꯁꯔꯨꯁꯤꯡ ꯑꯗꯨꯁꯨ ꯑꯁꯣꯀꯄꯥ ꯂꯩꯕ꯭ꯔꯥ? ꯑꯔꯊ꯭ꯔꯥꯏꯇꯤꯁꯀꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ!

ꯅꯍꯥꯛꯅꯥ ꯑꯦꯟꯀꯤꯂꯣꯁꯤꯡ ꯁ꯭ꯄꯣꯟꯗꯤꯂꯥꯏꯇꯤꯁꯁꯨ ꯂꯩꯕ꯭ꯔꯥ? ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯂꯥꯌꯦꯡꯂꯤꯕꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯇꯤꯃꯒꯤ ꯃꯔꯃꯗꯥ ꯈꯉꯁꯤ!

💬 Patient Questions & Comments (0)

Have a question or experience to share? Post a comment or reply to other readers below.

🛡️ Plain Text Only • No Links
👤

No comments yet. Be the first to share your question or experience below.

⚠️ Important: Medical articles and information on Nirogi Lanka are strictly for educational and awareness purposes and do not substitute professional medical advice, diagnosis, or treatment. Always consult a qualified physician for any medical concerns.